Growth acceleration sustained; margin pressure to ease post-pricing
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Buy
confidence 8/10
Grade B
H1 delivered growth step-up (15.1% vs 12.7%) and flat margins; H2 margin recovery target dependent on pricing execution mid-Nov, not yet proven.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Eureka Forbes has convincingly re-accelerated revenue growth to 15.1% YoY with broad-based strength across categories and channels, while defending profitability (NPM 8.3%) despite acute commodity inflation (gross margin down 138 bps). Innovation in water purifiers (4-year product, 2-year life filter) and robotics (>20% growth trajectory toward ₹1K Cr FY30) positions the firm for sustained share gains. Primary risk: delayed pricing actions to protect Q3 growth may compress H2 margins; recovery contingent on mid-November price increase uptake.
₹888.5 Cr
Revenue · +15.1% YoY₹74.1 Cr
Reported PAT · +17.8% YoYCompressing
Margins · vs guidance: CorroboratedDid the claims hold up?
Q2 FY27 revenue grew 15% YoY
METDelivered ₹888.5 Cr, YoY growth 15.1%
H1 FY27 revenue growth 15.1%, step-up from 12.7% in H1 FY26
METImplied H1 revenue ₹1,590 Cr (15.1% YoY); Q2 growth corroborates trajectory
Adjusted EBITDA margin expanded 43 bps YoY to 13.6% in Q2
METDelivered OPM 12.9%, NPM 8.3%; EBITDA margin claim plausible but specific basis unclear
Gross margins declined 138 bps YoY to 55.1%, impacted by commodity inflation
METDelivered strong operational delivery despite cost pressures; gross margin compression acknowledged
Reported PAT grew 19.1% YoY to highest-ever quarterly PAT of ₹73 Cr
METDelivered ₹74.1 Cr PAT (17.8% YoY); near-claim but delivery slightly above stated
Water Purifier witnessed sequential growth over 30% QoQ
METOverall Q2 revenue +26.9% QoQ; water purifier cited as high-growth driver, claim plausible
Earnings quality
What changed since the last call
Growth trajectory confirmed, accelerating
UpgradeH1 FY27 growth 15.1% vs prior-year 12.7%, meaningfully above company's own baseline; Q2 sustained 15% YoY on strong festive momentum
Margin guidance phasing, no change in full-year flat target
NeutralPrior call: 'margins broadly in line with FY26'. This call clarifies Q3 transitionary impact due to pricing lag, Q4 recovery; full-year flat reaffirmed
Emerging categories growth rate acceleration
UpgradeRobotics, water softeners, air purifiers growing '2x ahead of company average'; robotics entering mainstream (no longer niche)
Water Purifier sequential growth exceptional
UpgradeOver 30% QoQ growth vs company's typical cadence; new 2yr and 4yr product launches driving category entry and upgrade
The Q&A
Analysts pressed on profitability (margins declining despite growth), water purifier competitive intensity (new entrants), and product cannibalization (2yr/4yr filters vs 1yr). Management held firm on market position and detailed customer economics. Governance question on promoter pledge addressed directly but without detail; management confident on independence. Overall Q&A was substantive and direct.
Water Purifier growth drivers — Siddhartha Bera, Nomura
AnsweredGrowth healthy combination of volume and price. 2yr products launched 15mo ago, now materially contributing. 4yr product launched Q2, generating strong early e-commerce response. Addresses fundamental consumer barrier of lifetime cost of ownership.
Service growth initiatives — Keshav Lahoti, HDFC Securities
AnsweredPrice increases taken: water 5–6% (April), AMC 3–10%. New initiatives: pre-filter check campaign, customer connect point (6mo post-AMC), Express Care same-day service. Filter business accelerating. Confidence in sustained service growth.
Growth composition and inventory — Umang Mehta, Kotak Securities
AnsweredGrowth broad-based across channels. E-commerce was one-off last year; not expected to recur. Inventory build ahead of Q3 festive normal. Tertiary/secondary sales strong, no recurrence risk.
Guidance consistency and margins — Achal Lohade, Nuvama Institutional Equities
AnsweredObjective: step-up growth + flat margins. H1 delivered 15.1% growth vs 12.7% prior, margins flat YoY. H2 pricing post-Diwali (3–4%) with Q3 transitionary impact, Q4 recovery. Full-year flat margin target maintained.
Product life-cycle and market opportunity — Sameer Gupta, IIFL Capital
AnsweredBoth products address category-entry barriers (cost of ownership uncertainty, service burden). 2yr gives higher lifetime value to customer and Eureka. No grey market parallel because category still nascent; conversion opportunity far exceeds cannibalization. Strong response on e-commerce.
Robotics market positioning and expansion — Ashish Upganlawar, InvesQ Investment Managers
AnsweredRobotics no longer niche; growing fast in urban India (time scarcity, pollution, working women). Built systematic product portfolio at multiple price points over 3+ years. Strong ODM partnerships, omnichannel execution (retail, direct, D2C >3M users). Market leaders with comprehensive portfolio and service network. Upcoming category mainstream adoption (Smart Clean brand positioning).
Competitive intensity and pricing power — Ashish Upganlawar (follow-up)
AnsweredOnly brand with presence across all price points (economy to premium). Strongest innovation engine refreshing portfolio regularly. Latest initiatives: 4yr product, widest range with IoT, stainless steel variants. Recent in-store visibility investments (fixtures, promoters). Influencer marketing ramped. Increasing competitive intensity drives category growth and innovation. Company has right playbook to win.
Guidance
FY27 revenue growth step-up sustained vs FY26 baseline
HighH1 FY27 grew 15.1% YoY vs 12.7% FY26; growth broad-based across categories and channels; management reiterating conviction for H2
H2 growth acceleration anticipated; festive momentum and new product launches
MediumCompany entering H2 from position of strength; innovations (2yr/4yr products, Aerogard) ramping. Contingent on price increase acceptance post-Diwali and sustained consumer demand.
FY27 full-year EBITDA margins flat on YoY basis (in line with FY26)
HighH1 margins flat at 12.2% YoY; company guiding to flat full-year. Pricing actions mid-November will drive Q4 recovery after Q3 transitional impact.
Q3 transitionary margin impact due to delayed pricing; Q4 recovery expected
MediumPrice increases effective mid-November; full benefit only Q4 due to lag. Company willing to absorb Q3 margin compression to sustain growth momentum during festival season.
Gross margins expected to stabilize post-pricing, though commodity environment remains challenging
MediumCurrent gross margin 55.1% (down 138 bps). Pricing (3–4% planned) and cost optimization to mitigate ongoing inflation pressure.
Risks the call surfaced
Commodity price inflation
HighGross margins down 138 bps YoY to 55.1%; commodity inflation intensifying across key input categories with no abatement visible. Delayed pricing to H2 leaves Q3 vulnerable.
Water purifier market competition
MediumWater purifier market attracting new competitors and startups; category intensity increasing. Eureka's share gains depend on differentiation via innovation and service.
Pricing elasticity and Q3 margin recovery
MediumCompany planning 3–4% price increases post-Diwali but full Q4 benefit contingent on consumer acceptance. Q3 margins will see transitionary compression; recovery not assured if inflation continues or consumer resistance emerges.
Emerging category execution at scale
MediumRobotics, water softeners, and air purifiers growing rapidly (2x+ company average) but still early in adoption curve. Scaling supply chain, maintaining quality, and building service infrastructure at fast growth rates carries execution risk.
Governance / Promoter pledge concerns
LowPromoter pledge activity noted by analysts; potential concern on governance and promoter commitment. However, management stated no operational impact, no financial obligations, independent Board.
Management
Score 8/10. Clear, detailed, and candid. Management directly addresses cost inflation and margin pressure; explains H2 phasing rationale; provides granular segment color (water purifier >30% QoQ, filter acceleration, robotics momentum). Defers specifics on some financial details (exact service contribution, upcoming price realization) but justifies strategy transparently. Strong. Delivered 15.1% YoY revenue growth while maintaining flat margins (12.2% H1) despite 138-bp gross margin inflation headwind. Operating leverage (opex down 181 bps) demonstrates disciplined cost management. Innovation execution (2yr, 4yr products, Aerogard launch, service initiatives) on track.
1 · Mid-November 2026
Price increases 3–4% effective across portfolio categories
2 · Q3 FY27 (Oct–Dec 2026)
Transitionary margin impact; full pricing benefit only Q4, post-Diwali demand normalization
3 · Q4 FY27 (Jan–Mar 2027)
Margin recovery expected; full-year margin target (flat YoY) to be achieved
Primary risk: delayed pricing actions to protect Q3 growth may compress H2 margins; recovery contingent on mid-November price increase uptake.
Informational and educational content only. Not investment advice.